Recombinant Human Plasminogen protein (PLG) Active

Catalog No : IGX-RP2125-1MG
1155.34€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Recombinant Human Plasminogen protein (PLG) Active
Catalog No IGX-RP2125-1MG
Supplier’s Catalog No IGX-RP2125-1MG
Supplier ImuGeX
Source antigen Recombinant, expressed in E.Coli, 98-356 Amino Acids
Reactivity Rhesus macaque
Cross reactivity Rhesus macaque
Applications Functional studies, Bioassays or User optimised
Molecular weight 8.4 KDa
Storage Store at -20℃/-80℃.
Other names EC 3.4.21.7,
Grade Highly Purified
Purity >98% determined by SDS-PAGE and HPLC, Endotoxin Level: <1.0 EU/µg as determined by LAL method.
Form Lyophilized from a 0.2 μm filtered 20 mM NaAc, pH 5.5, 4 % mannitol
Reactivity life 12 months, when stored accoring to instructions.
Note For reserch purpose only, not for In Vivo use or as therapeutics.
Purity >98% determined by SDS-PAGE and HPLC, Endotoxin Level: <1.0 EU/µg as determined by LAL method.
Description Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invasion may be modulated by CSPG4. Binds to cells. Sequence: VYLSECKTGN GKNYRGTMSK TKNGITCQKW SSTSPHRPRF SPATHPSEGL EENYCRNPDN DPQGPWCYTT DPEKRYDYCD ILECEEECMH CSGENYDGKI SKTMSGLECQ AWDSQSPHAH GYIPSKFPNK NLKKNYCRNP DRELRPWCFT TDPNKRWELC DIPRCTTPPP SSGPTYQCLK GTGENYRGNV AVTVSGHTCQ HWSAQTPHTH NRTPENFPCK NLDENYCRNP DGKRAPWCHT TNSQVRWEYC KIPSCDSSP140. Biological Activity: Biologically Fully Active when compared to standard. The specific activity determined by an assay on anti-proliferation and anti-migration using endothelial cells in vitro and anti-angiogenesis in vivo is 5.5 × 105 IU/mg.